The Current Ratio as of November 2025 (TTM) for Promore Pharma AB (publ) (PROMO.ST) is 3.33

According to Promore Pharma AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.33. This represents a change of 10.76% compared to the average of 3.01 of the last 4 quarters.

Promore Pharma AB (publ) (PROMO.ST) Historical Current Ratio (quarterly & annually)

How has PROMO.ST Current Ratio performed in the past?

The mean historical Current Ratio of Promore Pharma AB (publ) over the last ten years is 6.70. The current 3.33 Current Ratio has changed 4.87% with respect to the historical average. Over the past ten years (40 quarters), PROMO.ST's Current Ratio was at its highest in in the September 2017 quarter at 19.57. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Promore Pharma AB (publ) (PROMO.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Promore Pharma AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Promore Pharma AB (publ) (PROMO.ST) Average Current Ratio

How has PROMO.ST Current Ratio performed in the past?

The current Current Ratio of Promore Pharma AB (publ) (PROMO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Promore Pharma AB (publ) (PROMO.ST) Current Ratio vs. Peers

How is PROMO.ST’s Current Ratio compared to its peers?

Promore Pharma AB (publ)’s Current Ratio is less than Medivir AB (publ) (4.39), greater than ISR Immune System Regulation Holding AB (publ) (3.27), greater than Idogen AB (publ) (1.67), greater than Asarina Pharma AB (publ) (1.20), less than Pharmiva AB (publ) (5.46), less than Kancera AB (publ) (8.02), greater than Ziccum AB (publ) (0.36), less than Cyxone AB (publ) (4.01), greater than Medhelp Care Aktiebolag (publ) (1.21), greater than Scandion Oncology A/S (1.81),

Build a custom stock screener for Promore Pharma AB (publ) (PROMO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Promore Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Promore Pharma AB (publ) (PROMO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Promore Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.